Analyst Reco. Hikma Pharmaceuticals PLC

Equities

HIK

GB00B0LCW083

Pharmaceuticals

Market Closed - London S.E. Other stock markets 10:05:02 13/03/2026 pm IST			5-day change	1st Jan Change
1,240.00 ^GBX	+2.56%		+2.56%	-20.00%

13/03	FTSE 100 falls as Hormuz uncertainty continues	AN
13/03	FTSE 100 Closes Week Lower as UK Economic Growth Stalls	MT

Analyst Reco.

03/03	Berenberg and RBC cut Beazley	AN
02/03	Price targets raised for BP and Shell	AN
26/02	Hikma Pharmaceuticals: Disappointing 2026 outlook and leadership turbulence rattle investors
09/01	Berenberg raises M&S; BofA cuts Barratt Redrow	AN
09/01	Hikma Pharmaceuticals faces tougher path to re-rating
07/01	Berenberg raises Vodafone; Barclays cuts Hikma	AN
10/11	UBS, Barclays cut Rightmove; RBC gives it raise	AN
07/11	Hikma Pharmaceuticals trims medium-term margins but keeps 2030 growth ambitions
07/11	Goldman Sachs cuts Weir; UBS ups British Land	AN
17/25/17	Diageo price targets cut but UBS keeps at 'buy'	AN
13/25/13	Watches of Switzerland cut; RBC lifts Genuit	AN
08/25/08	Hikma Pharmaceuticals: H1 beat; it's the mid-term outlook that is worth betting on
08/25/08	Goldman Sachs lifts Diageo; Shore cuts Renold	AN
09/25/09	Aviva and Dunelm cut, M&G raised	AN
03/25/03	Jefferies raises Hiscox, cuts Rio Tinto	AN
30/25/30	AlphaValue/Baader Europe Lifts Hikma's Price Target on 'Favorable' Long-Term Trends	MT
28/25/28	Hikma Pharmaceuticals: Well positioned to capitalise on the favourable longer-term dynamics
20/25/20	Berenberg Affirms Hikma Pharmaceuticals at Buy on 'Strong' Growth Outlook	MT
20/25/20	Kingfisher cut; Peel Hunt ups Oxford Nanopore	AN
14/25/14	BNP Paribas Exane Initiates Hikma Pharmaceuticals at Outperform	MT
14/25/14	RBC cuts AB Foods; JPMorgan raises Mondi	AN
25/25/25	Hikma Pharmaceuticals: Q1 in line with expectations; guidance unchanged
10/25/10	Jefferies Upgrades Hikma Pharmaceuticals to Buy, Raises PT	MT
10/25/10	Jefferies raises Hikma Pharmaceutical to 'buy'	AN
28/25/28	Barclays cuts WPP to 'equal weight'	AN